| |
| |
|
| Insider
Information: |
Scangos George A |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
937,662 |
|
|
Indirect Shares
|
3,762,360 |
|
|
| Direct
Value |
$29,796,828 |
|
|
|
Indirect Value
|
$4,756,396 |
|
|
| Total
Shares |
4,700,022 |
|
|
| Total
Value |
$34,553,224 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exelixis Inc |
EXEL |
Director |
2020-05-18 |
714,717 |
2020-05-18 |
23,595 |
Premium* |
|
|
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2008-08-26 |
33,188 |
2004-03-31 |
0 |
Premium* |
|
|
Biogen Idec Inc |
BIIB |
Chief Executive Office... |
2016-07-21 |
54,779 |
2016-07-21 |
10,756 |
Premium* |
|
|
Agilent Technologies Inc |
A |
Director |
2024-03-15 |
21,989 |
2024-03-15 |
14,450 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-02-26 |
112,989 |
2024-02-26 |
3,713,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
376 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 13 of 16
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2016-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,390 |
65,694 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2016-02-12 |
4 |
D |
$247.22 |
$2,920,904 |
D/D |
(11,815) |
60,335 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-02-12 |
4 |
D |
$392.11 |
$4,754,334 |
D/D |
(12,125) |
47,900 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-07-16 |
4 |
AS |
$312.37 |
$3,847,149 |
D/D |
(12,316) |
22,496 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2011-07-20 |
4 |
AS |
$105.94 |
$1,315,033 |
D/D |
(12,347) |
54,457 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,500 |
1,115,531 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
President and CEO |
• • – |
2023-02-23 |
4 |
AS |
$25.97 |
$328,065 |
D/D |
(12,631) |
183,608 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2016-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,701 |
58,628 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2018-12-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
13,950 |
1,443,031 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2018-05-15 |
4 |
OE |
$11.66 |
$174,900 |
D/D |
15,000 |
1,478,648 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-05-02 |
4 |
AS |
$20.00 |
$300,000 |
D/D |
(15,000) |
1,233,031 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-05-21 |
4 |
OE |
$4.57 |
$68,550 |
D/D |
15,000 |
1,248,031 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-06-04 |
4 |
AS |
$20.00 |
$300,000 |
D/D |
(15,000) |
1,208,031 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-04-24 |
4 |
AS |
$26.24 |
$393,600 |
D/D |
(15,000) |
738,031 |
0 |
% |
|
| VIR |
Vir Biotechnology, Inc. |
President and CEO |
• • – |
2023-02-24 |
4 |
AS |
$22.74 |
$352,682 |
D/D |
(15,119) |
168,489 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,599 |
45,547 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-04-07 |
4 |
AS |
$18.25 |
$299,939 |
D/D |
(16,435) |
945,096 |
0 |
% |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2024-02-20 |
4 |
AS |
$10.22 |
$172,385 |
D/D |
(16,872) |
140,739 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-07-16 |
4 |
D |
$144.61 |
$2,556,560 |
D/D |
(17,679) |
67,577 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2024-02-26 |
4 |
AS |
$11.65 |
$206,522 |
D/D |
(17,722) |
112,989 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
President and CEO |
• • – |
2022-02-18 |
4 |
AS |
$30.65 |
$543,304 |
D/D |
(17,726) |
112,989 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
President and CEO |
• • – |
2023-02-21 |
4 |
AS |
$28.02 |
$505,318 |
D/D |
(17,856) |
196,239 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,833 |
73,290 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2013-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,833 |
65,791 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,833 |
64,297 |
0 |
- |
|
376 Records found
|
|
Page 13 of 16 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
